Scientists Are Reexamining The Link Between Vitamin B12 And Cancer Risk

Vitamin B12 has long been promoted as a crucial nutrient for energy production, brain health, and red blood cell formation. However, as supplement use continues to rise worldwide, scientists are uncovering a more complicated relationship between B12 levels and cancer. The emerging message is not fear, but balance.

Also known as cobalamin, vitamin B12 plays a critical role in DNA synthesis and cell division. It is naturally found in animal-based foods such as meat, fish, eggs, and dairy products, as well as in fortified foods including some breakfast cereals. Most people who eat a varied diet obtain adequate amounts without difficulty.

Certain groups, however, are more vulnerable to deficiency. Vegans, older adults, individuals who have undergone weight-loss or bowel surgery, and people with conditions such as pernicious anemia or inflammatory bowel disease often depend on supplements. Untreated deficiency can lead to anemia, nerve damage, and cognitive impairment.

Why Vitamin B12 Matters For Cells

Every time a cell divides, it must accurately replicate its DNA. Alongside folate, vitamin B12 helps ensure this process functions properly. When B12 levels become too low, faulty DNA replication may occur, potentially increasing cancer risk over time, especially in rapidly dividing tissues such as the intestines.

For this reason, vitamin B12 deficiency is taken seriously in clinical medicine. Large observational studies have linked chronic deficiency and related folate disturbances to higher rates of colorectal cancer. Correcting deficiency is considered a routine part of preventive and supportive care.

However, the same property that makes B12 essential for healthy cells—supporting cell growth and division—also raises questions when levels become excessively high. In theory, if pre-cancerous or cancerous cells are already present, abundant growth-supporting nutrients could potentially encourage their proliferation as well.

What Research Says About High B12

Recent research has attempted to clarify this potential risk. A 2025 case-control study from Vietnam reported a U-shaped relationship between B12 intake and overall cancer risk, meaning that both very low and very high intakes were associated with increased cancer incidence. The study did not prove causation but highlighted the importance of maintaining moderate levels.

Larger analyses of B vitamin supplementation have generally failed to demonstrate broad cancer-protective effects from high-dose supplements. Randomized clinical trials in which participants took large doses of vitamins B6, B9, and B12 over multiple years showed little or no reduction in total cancer incidence or cancer-related mortality.

Some observational studies have also raised concerns about specific cancers. One widely discussed cohort study in the United States found a higher risk of lung cancer among men—particularly smokers—who used high-dose B6 and B12 supplements long term. Because smoking is such a major confounding factor, researchers stressed that the findings did not prove the supplements directly caused cancer.

At the same time, isolated findings suggesting possible benefits have also appeared. One pooled analysis indicated a lower melanoma risk with certain B vitamin regimens. However, experts caution that such isolated results should not be interpreted as evidence that high-dose vitamins prevent cancer in the general population.

High B12 Levels In Blood Tests And Cancer

A separate but related question involves why many cancer patients show unusually high B12 levels in blood tests. Studies published in 2022 and 2024 concluded that elevated B12 often appears as an epiphenomenon—meaning it accompanies cancer rather than directly causing it.

Researchers believe two main mechanisms may explain this effect. First, the liver stores large amounts of B12 and may release more of it into the bloodstream when damaged or stressed by tumors or metastases. Second, some cancers appear to increase production of B12-binding proteins, which raises measured blood levels even if tissues are not actually using more vitamin B12.

For clinicians, persistently elevated B12 is therefore considered a potentially important signal rather than definitive proof of cancer. When unusually high levels cannot be explained by supplements or injections, doctors may investigate for underlying liver disease, blood disorders, or previously undiagnosed malignancies.

A Possible Marker For Prognosis

Recent studies also suggest that vitamin B12 levels may help predict how certain cancers progress. A large study involving colon cancer patients found that those with very high B12 blood levels had a median survival of approximately five years, compared with nearly eleven years among patients whose levels remained within the normal range.

Similar associations have been reported in oral cancers and in patients receiving immunotherapy for different tumors. In some cases, elevated B12 correlated with poorer outcomes, suggesting it may reflect more aggressive disease or a greater tumor burden.

Researchers emphasize that this does not mean lowering B12 levels would improve survival. Instead, B12 may function as a convenient biomarker reflecting underlying processes such as liver involvement, inflammation, or altered binding proteins, all of which are themselves linked to prognosis.

What This Means For Supplements

For most people, normal dietary intake of vitamin B12 through food is not considered a concern. Reaching harmful levels through meat, fish, eggs, dairy products, or fortified foods alone is extremely difficult. Deficiency remains both more common and more clearly harmful than excess.

The primary concern involves long-term use of very high-dose supplements far above standard daily requirements, particularly without medical supervision. Some supplements and injections contain hundreds or even thousands of times the recommended daily intake despite limited evidence that such doses benefit otherwise healthy individuals.

Experts increasingly support a more targeted approach. People with confirmed deficiency, absorption problems, or strict vegan diets may genuinely require supplementation, and in such cases B12 replacement is essential. For individuals with normal levels, however, megadoses may add cost and uncertainty without proven cancer-preventive benefits.

Finding The Right Balance

Cancer prevention is unlikely to come from consuming excessive amounts of a single vitamin. Decades of nutrition research consistently show that overall dietary patterns, physical activity, smoking status, alcohol intake, weight management, and participation in screening programs have a far greater influence on cancer risk and survival.

For vitamin B12, the practical guidance remains relatively simple. Ensuring adequate intake is important, especially for older adults, vegans, people taking medications that affect stomach acid, or individuals with conditions that impair nutrient absorption. In these situations, testing and personalized supplementation can be appropriate.

At the same time, persistently and unexplainedly high B12 levels on blood tests should prompt further medical evaluation rather than reassurance. Such findings may indicate underlying disease that warrants investigation, even if vitamin B12 itself is not the direct cause.

Ongoing research is continuing to explore how B12 metabolism interacts with tumor biology and immune responses. As scientists learn more, they hope vitamin B12 will ultimately be viewed not as a simple villain or miracle nutrient, but as one important piece within the complex puzzle of cancer detection and management.